Yu-Qiong Zou

The levels of macrophage migration inhibitory factor as an indicator of disease activity and severity in adult-onset Still's disease.

Shun-le Chen, C. Bao, Xiao-dong Wang, 2008, Clinical biochemistry.

Sociodemographic factors as determinants of disease, disability and quality of life trajectories in early rheumatoid arthritis: A multi‐ethnic inception cohort study

P. Cheung, Cynthia Chen, M. Lahiri, 2019, International journal of rheumatic diseases.

The clinical significance of HRCT in evaluation of patients with rheumatoid arthritis-associated interstitial lung disease: a report from China

Yu-Qiong Zou, Xiaohui Ding, Ya-Song Li, 2012, Rheumatology International.

Roles of macrophage migration inhibitory factor in polymyositis: Inflammation and regeneration

Yu-Qiong Zou, Wei-dong Jin, Ya-Song Li, 2017, The Journal of international medical research.

Clinical, pathological and loss of heterozygosity differences in Wilms tumors between Asian and non‐Asian children

B. Teh, A. Loh, A. Tan, 2018, International journal of cancer.

New insights into the role and mechanism of macrophage migration inhibitory factor in steroid-resistant patients with systemic lupus erythematosus

M. Weisman, D. Wallace, N. Shen, 2012, Arthritis Research & Therapy.

SAT0675 SERUM CALPROTECTIN IN EARLY RHEUMATOID ARTHRITIS: ASSOCIATION WITH DISEASE ACTIVITY AND CLINICAL REMISSION

B. Dharmadhikari, P. Cheung, M. Lahiri, 2019, Saturday, 15 June 2019.

Clinical Features and Prognosis of Adult-onset Still’s Disease: 61 Cases from China

Chengde Yang, Ting Zeng, Yu-Qiong Zou, 2009, The Journal of Rheumatology.